Exxon Mobil profit drops 68% as fuel demand falls

Exxon Mobil Corp. reported a fourth straight drop in profit Thursday after demand fell for fuels to run cars, factories and airplanes.

Third-quarter net income declined 68% to $4.73 billion, or 98 cents a share, from $14.8 billion, or $2.85, a year earlier, the Irving, Texas, company said. Per-share profit was 4 cents lower than the average analyst estimate compiled by Bloomberg.

Exxon Mobil's revenue plunged 40% to $82.3 billion. Global oil demand fell enough to fill 62 supertankers, spurring a drop of almost $50 in the average price of a barrel of crude, and U.S. natural-gas futures dropped 62% as factories were idled by the recession.

Exxon Mobil's U.S. refineries, which generated profit of $978 million a year earlier, lost about $2.3 million a day as fuel prices slumped. The company said it was halving share buybacks to $2 billion in the current quarter.

Shares of Exxon Mobil rose 12 cents to $73.96.

PG&E

Higher rates help boost net income

PG&E Corp. said third-quarter profit rose 4.6% as its Pacific Gas & Electric utility, California's largest, collected higher rates to cover the cost of system maintenance and upgrades.

Net income climbed to $318 million, or 83 cents a share, from $304 million, or 83 cents, a year earlier, the San Francisco company said. Excluding one-time items, such as costs for gas-system maintenance and severance, profit was 93 cents a share, beating by 1 cent the average analyst estimate compiled by Bloomberg.

Third-quarter revenue fell 12% to $3.24 billion. Power sales at the utility dropped 8.7% and natural gas sales plunged 24%.

The utility, which provides electricity to about 5.1 million homes and businesses and natural gas to 4.3 million, said it had cut jobs by about 2%.

PG&E shares fell 15 cents to $41.40.

ALLERGAN

Botox maker's profit rises 8.2%

Allergan Inc., maker of the wrinkle smoother Botox, said third-quarter profit rose 8.2% on higher sales of eye and skin-care treatments.

Net income increased to $179 million, or 58 cents a share, from $165.4 million, or 54 cents, a year earlier, the Irvine company said. Profit excluding one-time items was 70 cents a share, beating by 1 cent the average estimate of analysts surveyed by Bloomberg.

Revenue rose for many drugs including Botox, countering a decline seen earlier this year as consumers cut discretionary spending in the recession.

Allergan shares rose $1.37, or 2.6%, to $54.92.

REGAL

Cinema operator swings to a loss

Regal Entertainment Group, the largest U.S. cinema operator, reported a $1.8-million third-quarter loss on falling movie attendance.

The net loss of 1 cent a share contrasts with profit of $31 million, or 20 cents, a year earlier, the Knoxville, Tenn., company said. Sales fell 11% to $673.5 million, missing the $708.2-million average analyst estimate.

Excluding some items, profit in the three months ended Oct. 1 totaled 5 cents a share, compared with analysts' projections of 7 cents on average.

Shares of Regal, which also operates United Artists and Edwards theaters, rose 57 cents to $11.96.

-- times wire reports